eNLife Research raises INR6 crore seed round for Alzheimer’s biomarker research
Piper Serica leads funding to take the company’s first blood-based diagnostic assay toward clinical-grade validation.
The Bengaluru startup is working on an assay that combines blood biomarkers with AI-based analysis for earlier detection of neurodegenerative disease. Its founders include IISc neuroscientist Deepak Kumaran Nair, Jojo Jacob and Anish Mathew.
The programme focuses on developing evidence suited to Indian populations and a more accessible testing approach. The financing supports a research-to-validation step: the ambition to identify disease years before symptoms remains a development objective.
Use of funds
Validate the blood-based biomarker platform
Expand the research and development team
Advance the first diagnostic assay to clinical-grade validation